27th November 2018

Mirada Medical to form part of UK government’s AI in healthcare revolution

Oxford (UK) 27th November 2018 - Mirada Medical, a leading global brand in medical imaging software, will form part of a consortium receiving £50M in new funding from the UK government, as part of its drive to expedite the development and adoption of Artificial Intelligence in healthcare and the NHS.

Mirada has already achieved global leadership in medical AI by developing the first Deep Learning applications for radiotherapy planning to receive regulatory clearance for clinical use in both Europe and the USA. The company will bring its expertise and practical experience to projects hosted by Kings College London and the University of Oxford, two of the five centers funded through Wave 2 of the Industrial Strategy Challenge Fund’s ‘Data to Early Diagnosis and Precision Medicine’ initiative.

Mirada will be partnering with the London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare, led by Kings College London, and will be working closely with Guys & St Thomas hospital. Mirada will be building on its success in commercializing its DLCExpert TM radiation therapy planning application to deliver the potential of AI to the NHS and demonstrate how advanced medical imaging and deep learning technologies can be used to improve patient care.

Mirada will also partner with the University of Oxford’s NCIMI (National Consortium of Intelligent Medical Imaging) to investigate the role that AI and deep learning can play in diagnostic nuclear medicine. The company will be building on its established partnership with the Alliance Medical Group and the NHS PET scanning program, where Mirada software is already used to read more than half of the PET/CT scans in England & Wales.

These initiatives will improve the efficiency of cancer detection and diagnosis, leading to faster cancer treatment delivery, cost reductions for the NHS, and improved patient outcomes.

“At Alliance Medical we consider Mirada a valued partner, supporting our PET-CT services to patients across the UK and hope to continue this partnership in support of the NCIMI and their ground-breaking research. This forms part of our commitment to work with best-in-class companies and research institutions to advance and improve diagnostic services to patients,” commented Mark Ferreira, UK Medical Director at Alliance Medical.

Commenting on Mirada’s involvement, Centre Director Professor Reza Razavi from King’s College London said: “The Centre will provide a fantastic opportunity to transform 12 different patient pathways by using advanced imaging and AI and help make the products that will substantially improve the experience for our patients and their clinical outcomes. It will also allow us to better utilize the resources within the NHS. This builds on a great ongoing partnership between our researchers, clinicians and industry colleagues that will help put the UK at the forefront of developing and applying new technologies to improve healthcare.”

Mark Gooding, Chief Scientist at Mirada Medical added: “We are excited to be co-operating with these prestigious institutions and are determined to continue to improve healthcare outcomes and NHS pathways through our ongoing development of AI-based imaging software applications.”



Mirada Medical is a leading international brand in medical imaging. The company develops advanced technology applications that help healthcare professionals use medical images more effectively and efficiently to improve cancer care. Mirada’s products are used across diagnostic radiology, molecular imaging, radiation oncology, medical oncology, tumor board and elsewhere.

The company specializes in simplifying technically complex image processing tasks, allowing clinicians to more confidently diagnose disease, assess response to treatment, and plan radiation therapy or surgical intervention. Mirada’s advanced technology products are available throughout the world under its own brand, and on an OEM basis through a select number of the world’s leading healthcare companies.


Mirada Medical and DLCExpert are trademarks of Mirada Medical Ltd.


To learn more about Mirada Medical, please visit: www.mirada-medical.com

For more information, please contact info@mirada-medical.com